Answers are grounded in this paper and cite their sources.
T-regulatory cells suppress anti-tumour immunity in cancer patients and in murine tumour models. Furthermore, their activity is likely to have an effect on the effectiveness of immunotherapeutic treatments for cancer. Here we describe the current status of developing clinical strategies for modulating Treg activity in cancer patients.
No takes yet. Share an insight, caveat, or question.
Nizar et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: